First PREMIER Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $378K | Hold |
15,632
| – | – | 0.06% | 140 |
|
|
2026
Q1 | $440K | Buy |
15,632
+865
| +6% | +$23K | 0.1% | 122 |
|
|
2025
Q4 | $368K | Sell |
14,767
-1,530
| -9% | -$38.6K | 0.08% | 128 |
|
|
2025
Q3 | $416K | Sell |
16,297
-14,056
| -46% | -$347K | 0.09% | 124 |
|
|
2025
Q2 | $736K | Sell |
30,353
-1,204
| -4% | -$28.1K | 0.18% | 93 |
|
|
2025
Q1 | $801K | Sell |
31,557
-560
| -2% | -$14.7K | 0.2% | 87 |
|
|
2024
Q4 | $852K | Sell |
32,117
-4,023
| -11% | -$109K | 0.22% | 83 |
|
|
2024
Q3 | $1.04M | Sell |
36,140
-31,013
| -46% | -$905K | 0.26% | 77 |
|
|
2024
Q2 | $1.88M | Sell |
67,153
-9,486
| -12% | -$261K | 0.5% | 56 |
|
|
2024
Q1 | $2.13M | Sell |
76,639
-3,966
| -5% | -$110K | 0.56% | 51 |
|
|
2023
Q4 | $2.32M | Sell |
80,605
-7,894
| -9% | -$239K | 0.65% | 44 |
|
|
2023
Q3 | $2.94M | Sell |
88,499
-350
| -0.4% | -$12.4K | 0.9% | 35 |
|
|
2023
Q2 | $3.26M | Sell |
88,849
-617
| -0.7% | -$24K | 0.93% | 32 |
|
|
2023
Q1 | $3.65M | Sell |
89,466
-1,217
| -1% | -$52.6K | 1.06% | 28 |
|
|
2022
Q4 | $4.65M | Buy |
90,683
+430
| +0.5% | +$20.6K | 1.41% | 21 |
|
|
2022
Q3 | $3.95M | Buy |
90,253
+214
| +0.2% | +$10.4K | 1.29% | 24 |
|
|
2022
Q2 | $4.72M | Sell |
90,039
-123
| -0.1% | -$6.27K | 1.41% | 20 |
|
|
2022
Q1 | $4.67M | Buy |
90,162
+265
| +0.3% | +$13.8K | 1.23% | 26 |
|
|
2021
Q4 | $5.31M | Buy |
89,897
+24
| +0% | +$1.19K | 1.37% | 22 |
|
|
2021
Q3 | $3.87M | Buy |
89,873
+110
| +0.1% | +$4.87K | 1.1% | 30 |
|
|
2021
Q2 | $3.52M | Buy |
89,763
+1,305
| +1% | +$50.7K | 1.01% | 30 |
|
|
2021
Q1 | $3.2M | Sell |
88,458
-1,486
| -2% | -$52.8K | 1.13% | 29 |
|
|
2020
Q4 | $3.31M | Sell |
89,944
-3,336
| -4% | -$122K | 1.31% | 23 |
|
|
2020
Q3 | $3.25M | Sell |
93,280
-280
| -0.3% | -$9.82K | 1.43% | 24 |
|
|
2020
Q2 | $2.9M | Buy |
93,560
+6,573
| +8% | +$223K | 1.4% | 23 |
|
|
2020
Q1 | $2.69M | Buy |
86,987
+317
| +0.4% | +$10.8K | 1.5% | 21 |
|
|
2019
Q4 | $3.22M | Sell |
86,670
-2,166
| -2% | -$77.2K | 1.51% | 18 |
|
|
2019
Q3 | $3.03M | Buy |
88,836
+117
| +0.1% | +$4.25K | 1.57% | 18 |
|
|
2019
Q2 | $3.65M | Hold |
88,719
| – | – | 1.99% | 14 |
|
|
2019
Q1 | $3.58M | Buy |
88,719
+333
| +0.4% | +$13.3K | 2.06% | 14 |
|
|
2018
Q4 | $3.66M | Buy |
88,386
+795
| +0.9% | +$33K | 2.36% | 9 |
|
|
2018
Q3 | $3.66M | Sell |
87,591
-268
| -0.3% | -$10.3K | 2.26% | 12 |
|
|
2018
Q2 | $3.02M | Buy |
87,859
+2,782
| +3% | +$95.1K | 2.03% | 12 |
|
|
2018
Q1 | $2.86M | Sell |
85,077
-720
| -0.8% | -$24.8K | 2.1% | 11 |
|
|
2017
Q4 | $2.95M | Sell |
85,797
-3,162
| -4% | -$108K | 2.03% | 14 |
|
|
2017
Q3 | $3.01M | Buy |
88,959
+14,822
| +20% | +$476K | 2.11% | 13 |
|
|
2017
Q2 | $2.36M | Buy |
74,137
+4,956
| +7% | +$156K | 1.78% | 18 |
|
|
2017
Q1 | $2.25M | Buy |
69,181
+18,125
| +36% | +$571K | 1.7% | 19 |
|
|
2016
Q4 | $1.57M | Sell |
51,056
-732
| -1% | -$22.3K | 1.2% | 26 |
|
|
2016
Q3 | $1.66M | Buy |
51,788
+5,050
| +11% | +$169K | 1.25% | 25 |
|
|
2016
Q2 | $1.56M | Buy |
46,738
+2,281
| +5% | +$72.8K | 1.19% | 25 |
|
|
2016
Q1 | $1.25M | Buy |
44,457
+1,397
| +3% | +$39.9K | 1% | 32 |
|
|
2015
Q4 | $1.32M | Buy |
+43,060
| New | +$1.35M | 1.12% | 27 |
|
Other funds holding PFE
First PREMIER Bank's PFE Position: Q2 2026 in Review
First PREMIER Bank held its Pfizer (PFE) position steady in Q2 2026 at 15,632 shares worth $378K. The position accounts for 0.06% of the portfolio, ranked #140.
First PREMIER Bank first reported a position in PFE in Q4 2015 and has held it in 43 quarters since. The position peaked at $5.31M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- First PREMIER Bank held 15,632 shares of Pfizer worth $378K as of Q2 2026.
- First PREMIER Bank left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.06% of First PREMIER Bank's portfolio in Q2 2026, its #140 holding.
- First PREMIER Bank first reported a position in Pfizer in Q4 2015 and has held it in 43 quarters since.
- First PREMIER Bank's Pfizer position peaked at $5.31M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on First PREMIER Bank's 13F filing for Q2 2026, filed 15 Jul 2026.